Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions his Department has had with the Scottish Government regarding the availability and UK-wide supply of flu and RSV vaccines this winter; and what steps are being taken at a UK level to support devolved administrations in managing winter pressures related to respiratory illness.

The UK Health Security Agency (UKHSA) works closely with flu vaccine manufacturers and suppliers to maintain high level oversight of the overall United Kingdom supply of flu vaccine for adults. This enables early identification and mitigation of potential risks to programme delivery, such as constraints in dose availability or delays to deliveries.

The UKHSA procures the respiratory syncytial virus (RSV) vaccine and the live attenuated influenza vaccine (LAIV), which is the primary vaccine used in the children’s flu programme, on a UK wide basis. As such, the UKHSA liaises regularly with all devolved nations, including the Scottish administration, on procurement activities and supply arrangements for these vaccines.

Both the RSV vaccine and LAIV are available for Scottish Health Boards to order via the UKHSA’s online ordering platform, ImmForm, ensuring consistent access across the UK.

Ensuring timely and reliable access to flu and RSV vaccines is a key part of reducing the burden of respiratory illness over the winter period, helping to limit avoidable hospital admissions and support health systems, including those in devolved administrations, in managing winter pressures.